FR2260337A1 - - Google Patents

Info

Publication number
FR2260337A1
FR2260337A1 FR7503688A FR7503688A FR2260337A1 FR 2260337 A1 FR2260337 A1 FR 2260337A1 FR 7503688 A FR7503688 A FR 7503688A FR 7503688 A FR7503688 A FR 7503688A FR 2260337 A1 FR2260337 A1 FR 2260337A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7503688A
Other languages
French (fr)
Other versions
FR2260337B1 (pt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2260337A1 publication Critical patent/FR2260337A1/fr
Application granted granted Critical
Publication of FR2260337B1 publication Critical patent/FR2260337B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7503688A 1974-02-08 1975-02-06 Expired FR2260337B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH177374A CH585693A5 (pt) 1974-02-08 1974-02-08

Publications (2)

Publication Number Publication Date
FR2260337A1 true FR2260337A1 (pt) 1975-09-05
FR2260337B1 FR2260337B1 (pt) 1978-07-21

Family

ID=4218257

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7503688A Expired FR2260337B1 (pt) 1974-02-08 1975-02-06

Country Status (22)

Country Link
JP (2) JPS6044292B2 (pt)
AT (1) AT334880B (pt)
BE (1) BE825289A (pt)
CA (1) CA1053705A (pt)
CH (1) CH585693A5 (pt)
CS (1) CS199571B2 (pt)
DE (1) DE2503751C2 (pt)
DK (1) DK135800B (pt)
ES (1) ES434540A1 (pt)
FR (1) FR2260337B1 (pt)
GB (1) GB1470039A (pt)
HK (1) HK87279A (pt)
HU (1) HU174113B (pt)
IE (1) IE40590B1 (pt)
IL (1) IL46592A (pt)
KE (1) KE3007A (pt)
MX (1) MX3831E (pt)
MY (1) MY8000199A (pt)
NL (1) NL7501496A (pt)
SE (1) SE412905B (pt)
YU (5) YU39313B (pt)
ZA (1) ZA75799B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202978A (en) * 1978-02-08 1980-05-13 Hoffmann-La Roche Inc. (S)-1-[2-(4-(2-Hydroxy-s-(1-alkylaminopropoxy)phenylalkyl]-4-phenylpiperazines
US4294966A (en) * 1978-07-28 1981-10-13 Ciba-Geigy Corporation Process for inverting the configuration in optically active compounds
GB2119366B (en) * 1979-03-01 1984-04-11 Siemens Spa Italiana The levorotatory isomer of moprolol and pharmaceutical compositions thereof
JPH0419666Y2 (pt) * 1985-09-30 1992-05-06
JPS62150579A (ja) * 1985-12-25 1987-07-04 Matsushita Electric Ind Co Ltd ラジオ受信機付カセツトテ−プレコ−ダ
ZA991319B (en) 1998-02-20 2000-11-20 Ortho Mcneil Pharm Inc Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (pt) * 1962-12-11
GB1136919A (en) * 1965-06-16 1968-12-18 Ici Ltd Amines
CH509265A (de) * 1967-01-04 1971-06-30 Spofa Vereinigte Pharma Werke Verfahren zur Herstellung von neuen Trimethylhydrochinonderivaten
SE372762B (pt) * 1969-05-21 1975-01-13 Haessle Ab
ZA732136B (en) * 1972-04-12 1974-03-27 Lilly Co Eli Dopamine derivatives

Also Published As

Publication number Publication date
DK135800C (pt) 1977-12-12
DK645474A (pt) 1975-09-29
AT334880B (de) 1977-02-10
BE825289A (fr) 1975-08-07
FR2260337B1 (pt) 1978-07-21
KE3007A (en) 1979-12-14
JPS6044292B2 (ja) 1985-10-02
DE2503751A1 (de) 1975-08-14
MY8000199A (en) 1980-12-31
YU39267B (en) 1984-10-31
YU123481A (en) 1984-10-31
SE412905B (sv) 1980-03-24
CA1053705A (en) 1979-05-01
DK135800B (da) 1977-06-27
YU27075A (en) 1982-06-30
ATA90275A (de) 1976-06-15
AU7795475A (en) 1976-08-12
ES434540A1 (es) 1976-12-16
GB1470039A (en) 1977-04-14
CS199571B2 (en) 1980-07-31
IE40590B1 (en) 1979-07-04
HK87279A (en) 1979-12-28
HU174113B (hu) 1979-11-28
JPS6064951A (ja) 1985-04-13
IL46592A (en) 1978-03-10
JPS50108228A (pt) 1975-08-26
IE40590L (en) 1975-08-08
ZA75799B (en) 1976-01-28
YU123681A (en) 1982-06-30
NL7501496A (nl) 1975-08-12
YU123781A (en) 1982-06-30
SE7500205L (pt) 1975-08-11
IL46592A0 (en) 1975-04-25
DE2503751C2 (de) 1986-05-22
MX3831E (es) 1981-08-04
YU123581A (en) 1982-06-30
CH585693A5 (pt) 1977-03-15
YU39313B (en) 1984-10-31

Similar Documents

Publication Publication Date Title
DK499275A (pt)
FR2261958B1 (pt)
FR2294718B1 (pt)
FR2284051B1 (pt)
FR2273282B1 (pt)
FR2260337B1 (pt)
FR2279485B1 (pt)
FR2276449B1 (pt)
FR2269091A1 (pt)
FR2278714B1 (pt)
FR2257681B1 (pt)
JPS50101367U (pt)
JPS50102094U (pt)
JPS50102962U (pt)
FI753518A (pt)
BG22732A1 (pt)
BG21353A1 (pt)
CH1107074A4 (pt)
BG19873A1 (pt)
BG26152A1 (pt)
BG23188A1 (pt)
BG19828A1 (pt)
BG19954A1 (pt)
BG22309A1 (pt)
BG22203A1 (pt)

Legal Events

Date Code Title Description
ST Notification of lapse